Vaccines have represented the breakthrough in the fight against COVID-19. Based on
reported headache attacks after vaccination in randomized controlled trials, we focused on …

Background Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination.
Whether patients with history of headache suffer more from vaccination-induced headaches …

Recent evidence suggests that headache is common in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections [1]. Although universal vaccination appears the …

Background This longitudinal cohort study aimed to investigate changes in migraine-related
outcomes following COVID-19 infection and vaccination. Methods We identified 547 …

Objective The objective is to summarize the knowledge on the epidemiology,
pathophysiology and management of secondary headache attributed to SARS-CoV-2 …

Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite …

The coronavirus disease 2019 (COVID‐19) pandemic has rapidly transformed the whole
world and forced us to look through comorbid diseases and risk factors from a different …

Introduction Headache is a frequent adverse event after viral vaccines. We aimed to
investigate the frequency and clinical associations of COVID-19 vaccine-related headache …

Background Headache is the most frequent neurological adverse event following SARS-
CoV-2 vaccines. We investigated the frequency, characteristics, and factors associated with …

Abstract Background Coronavirus disease-19 (COVID-19) due to acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection is the largest emergency that humanity had …